Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical VDA-1102 ointment for actinic keratosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• VDA-1102 ointment (VDA-1102)

Snippet

Sponsor: Vidac Pharma | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2022-08-23